Caris Molecular Intelligence Registry

Caris Science, Inc.4,981 enrolled

Overview

This data collection Registry is a multi-center, observational outcomes Database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, quality of life and outcomes of subjects utilizing Caris Molecular Intelligence™ Services for treatment of solid tumor cancer.

Study Type

OBSERVATIONAL

Enrollment

4,981

Conditions

Solid Tumors

Interventions

No intervention required, purely observationalOTHER

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age greater than or equal to 18 years, and * Solid Tumor analyzed by Caris Molecular Intelligence™ Service Profile(s) and/or Caris Next-Generation Sequencing Exclusion Criteria: * Individual test orders; defined as single biomarker assessment * Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoner-patients shall not be approached for participation in the Registry.

Outcomes

Primary Outcomes

Documentation of the frequency of specific clinical events in relation to risk factors, diagnosis and treatments provided.

Time frame: 5 years per patient

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.